Get the White Paper
Multimodal biomedical AI: Applications and challenges in pharma, MedTech, and healthcare
With the recent advancements in generative AI, and the ongoing explosion of multimodal biomedical data from large biobanks, electronic health records, medical imaging, and biosensors, it is now possible to capture the complexity of human health and disease more accurately.
These breakthroughs are unlocking new opportunities for enterprise AI solutions across healthcare, pharma, and medtech.
In this whitepaper, we’ll dig deeper into:
- What multimodal AI is and how it’s more impactful than single-modal AI in healthcare, pharma and medtech.
- How multimodal AI augments clinical trials, remote monitoring and care, pandemic surveillance, digital twin technology, virtual health assistants, and personalized medicine.
- How Grid Dynamics can support multimodal and generative AI applications in the healthcare, pharma and medtech industries.
Tags
You might also like
In the era of precision medicine and on-demand experiences, intelligent content management is the nervous system of pharma innovation and engagement. By seamlessly connecting data, insights, and knowledge across the organization, it accelerates discovery, enhances decision-making, and ultimate...
Against the backdrop of escalating healthcare costs, surpassing $6 trillion by 2028, and a looming shortage of 10 million health workers by 2030, the urgency of 100% digital health integration is stark. This alarming trajectory demands a shift towards prevention and proactive care to curtail skyroc...
In the pharma industry, composable commerce acts as a powerful alchemist, blending potent ingredients into a personalized elixir of success. Like a skilled alchemist mixing precise elements to create transformative potions, composable commerce seamlessly combines diverse digital capabilities, empow...
In a world where artificial intelligence (AI) is transforming industries, the pharmaceutical sector faces unique challenges in fully embracing this technological revolution. Often, the industry experiences a multitude of isolated AI pilot projects that struggle to transition into full-scale product...
The pharma and life sciences industry is experiencing a data revolution. As everything becomes more digital, the amount of biomedical data is exploding. This presents an opportunity to tap into valuable insights to advance R&D, manufacturing, marketing, and more. However, companies struggle to...
Intelligent interfaces are changing how applications are designed and built, moving from fixed screens to systems that can restructure themselves around the way people actually work. Instead of just swapping content, intelligent user interfaces can decide which components appear, how they are a...
Most enterprises are already betting big on AI… but very few have turned it into a reliable, industrial‑grade software factory. On the backend, most engineering leaders know they need AI SDLC, but few know how to measure whether they’re actually doing it well. Download the white paper to run a...

